Single‐Dose and Multiple‐Dose Pharmacokinetics and Dose Proportionality of Intravenous and Intramuscular HPβCD‐Diclofenac (Dyloject) Compared with Other Diclofenac Formulations
Authors:
Open Access
- 6 June 2013
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 33 (10) , 1012-1021
Abstract
Study Objective: To evaluate single‐ and repeated‐dose pharmacokinetics (PK) and dose proportionality of hydroxypropyl‐β‐cyclodextrin (HPβCD)‐diclofenac compared with Voltarol after intravenous (IV) and intramuscular (IM) administration.Design: Study 1: Single‐dose randomized four‐way crossover study. Study 2: Multiple‐dose randomized three‐way crossover study.Setting: Clinical research center.Subjects: Healthy adult volunteers.Intervention: Study 1: Subjects received HPβCD‐diclofenac and Voltarol, IV and IM, with a 5‐day washout between treatment periods. Study 2: Subjects received two doses of IV HPβCD‐diclofenac and oral Cataflam once every 6 hours for four doses with a 48‐hour washout period between treatment periods.Measurements and Main Results: Study 1: IV HPβCD‐diclofenac had a higher peak plasma concentration (Cmax) and earlier time to reach maximum plasma concentration (Tmax), but equivalent plasma exposure (area under the curve from time zero to t [AUC0–t]) to IV Voltarol. The geometric mean ratio of HPβCD‐diclofenac (IV) to Voltarol (IV) for AUC0–t was 106.27%. The geometric mean ratio of HPβCD‐diclofenac (IM) to Voltarol (IM) for AUC0–t was 110.91%. The geometric mean ratio of HPβCD‐diclofenac (IV) to HPβCD‐diclofenac (IM) for AUC0–t was 101.25%. The geometric mean ratio of HPβCD‐diclofenac (IM) to Voltarol (IV) for AUC0–t was 104.96%. Study 2: Cmax for diclofenac was 2904 and 6031 ng/ml after the first IV dose of 18.75 and 37.5 mg HPβCD‐diclofenac, respectively, and was 3090 and 5617 ng/ml after the fourth dose, indicating no accumulation. Plasma exposures to 18.75 mg (866 ng·hour/ml) and 37.5 mg (1843 ng·hour/ml) IV HPβCD‐diclofenac bracketed that of oral Cataflam 50 mg (1473 ng·hour/ml).Conclusions: Study 1: Bioavailability in terms of AUC after IV administration was equivalent for HPβCD‐diclofenac compared with Voltarol and after IM administration of HPβCD‐diclofenac and Voltarol. Bioavailability in terms of AUC after IM administration of HPβCD‐diclofenac was equivalent to IV administration of HPβCD‐diclofenac and IV administration of Voltarol. Study 2: HPβCD‐diclofenac showed dose proportionality after single‐ and multiple‐dose administration and no accumulation of HPβCD‐diclofenac. HPβCD‐diclofenac was safe and well tolerated following IV and IM administration.Keywords
This publication has 18 references indexed in Scilit:
- Analgesic Efficacy and Safety of a Novel Injectable Formulation of Diclofenac Compared With Intravenous Ketorolac and Placebo After Orthopedic SurgeryThe Clinical Journal of Pain, 2013
- A Double-Blind Placebo-Controlled Comparison of a Novel Formulation of Intravenous Diclofenac and Ketorolac for Postoperative Third Molar Extraction PainAnesthesia Progress, 2011
- Dyloject®, a novel injectable diclofenac solubilised with cyclodextrin: Reduced incidence of thrombophlebitis compared to injectable diclofenac solubilised with polyethylene glycol and benzyl alcoholAcute Pain, 2009
- PPN2 A COST MINIMIZATION ANALYSIS OF IV BOLUS VERSUS IV INFUSION DICLOFENAC IN POST-OPERATIVE PAINValue in Health, 2007
- Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental PainRegional Anesthesia & Pain Medicine, 2007
- 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology reviewFood and Chemical Toxicology, 2005
- PropofolAnesthesiology, 2005
- Osmolalities of Propylene Glycol-Containing Drug Formulations for Parenteral Use. Should Propylene Glycol Be Used as a Solvent?Anesthesia & Analgesia, 1992
- Prophylactic diclofenac infusions in major orthopedic surgery: effects on analgesia and acute phase proteinsActa Anaesthesiologica Scandinavica, 1992
- Venous reactions related to in-dwelling plastic cannulae: a prospective clinical trialCurrent Medical Research and Opinion, 1976